title: Major depression after withdrawing dopamine agonists in two patients with restless legs syndrome and impulse control disorders.
authors.forename: Claire
authors.initials: C
authors.lastname: Launois
authors.forename: Smaranda
authors.initials: S
authors.lastname: Leu-Semenescu
authors.forename: Agnès
authors.initials: A
authors.lastname: Brion
authors.forename: Isabelle
authors.initials: I
authors.lastname: Arnulf
mesh_terms: D000369:Aged, 80 and over; D052160:Benzothiazoles / Q000008:administration & dosage / Q000009:adverse effects; D003865:Major Depressive Disorder / Q000139:chemically induced*; D007174:Disruptive, Impulse Control, and Conduct Disorders / Q000188:drug therapy*; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D000077487:Pramipexole; D012148:Restless Legs Syndrome / Q000188:drug therapy*; D013375:Substance Withdrawal Syndrome
chemical_list: D052160:Benzothiazoles; D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole; D000077487:Pramipexole